Gujarat Inject Kerala Ltd approves unaudited Q2 FY2026 results
Board approved the unaudited financial results for the quarter ended 30 June 2026, filed on 15 July 2026.
What Gujarat Inject Kerala Ltd announced
On 15 July 2026, Gujarat Inject Kerala Ltd (BSE: 524238) announced that its Board of Directors had approved the unaudited financial results for the quarter ended 30 June 2026. The filing, submitted to the Bombay Stock Exchange, contains a brief resolution confirming the approval but does not provide any quantitative financial data.
"The Board of Directors of Gujarat Inject Kerala Ltd has approved the unaudited financial results for the quarter ended on 30.06.2026."
Details of the board meeting
The resolution was filed under the heading "APPROVAL OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED ON 30.06.2026". The filing timestamp is 04:33:57 UTC on 15 July 2026. No further narrative, such as commentary on performance, segment-wise breakdown, or management discussion, accompanies the resolution. The document is a standard board‑meeting outcome filing, typical for Indian listed companies that disclose unaudited results before the audited statements are prepared.
Key facts at a glance
| Detail | Value |
|---|---|
| Company | Gujarat Inject Kerala Ltd |
| BSE ticker | 524238 |
| Filing date | 15 July 2026 (04:33:57 UTC) |
| Announcement type | Board meeting outcome – approval of unaudited results |
| Period covered | Quarter ended 30 June 2026 |
| Financial figures disclosed | None in the filing |
| Source document | d2980c16-2f5e-4da6-839c-ae1805937b5a.pdf |
Why this matters for investors
The approval of unaudited results signals that the company has completed its internal accounting for the quarter and is ready to present the numbers to shareholders, albeit without the assurance of an independent audit. While unaudited figures can give an early glimpse of performance, they are not subject to the same verification standards as audited statements. Investors should therefore treat the information as provisional and await the audited results, which will be filed later in accordance with SEBI regulations. The filing fulfills a statutory requirement and maintains transparency, but it does not, by itself, indicate any material change in the company’s financial position.
Conclusion
Gujarat Inject Kerala Ltd’s board has formally approved its unaudited financial results for the quarter ended 30 June 2026, as disclosed on 15 July 2026. No quantitative data were released in the filing, and the audited results are expected to follow in due course, providing the definitive financial picture for the period.
Frequently asked questions
Related stocks
Source filing: view original